280 related articles for article (PubMed ID: 37531778)
1. Controllable hypoxia-activated chemotherapy as a dual enhancer for synergistic cancer photodynamic immunotherapy.
Wang M; He M; Zhang M; Xue S; Xu T; Zhao Y; Li D; Zhi F; Ding D
Biomaterials; 2023 Oct; 301():122257. PubMed ID: 37531778
[TBL] [Abstract][Full Text] [Related]
2. Enhancing photodynamic immunotherapy by reprograming the immunosuppressive tumor microenvironment with hypoxia relief.
He M; Zhang M; Xu T; Xue S; Li D; Zhao Y; Zhi F; Ding D
J Control Release; 2024 Apr; 368():233-250. PubMed ID: 38395154
[TBL] [Abstract][Full Text] [Related]
3. Enzyme/GSH dual-responsive biodegradable nanohybrid for spatiotemporally specific photodynamic and hypoxia-augmented therapy against tumors.
Cheng D; Ji Y; Wang B; Jin T; Xu Y; Qian X; Zhu W
Int J Pharm; 2021 Jun; 603():120730. PubMed ID: 34029662
[TBL] [Abstract][Full Text] [Related]
4. Combinational phototherapy and hypoxia-activated chemotherapy favoring antitumor immune responses.
Ma B; Sheng J; Wang P; Jiang Z; Borrathybay E
Int J Nanomedicine; 2019; 14():4541-4558. PubMed ID: 31417257
[No Abstract] [Full Text] [Related]
5. A hybrid metal-organic framework nanomedicine-mediated photodynamic therapy and hypoxia-activated cancer chemotherapy.
Jia Z; Gao Y; Ni J; Wu X; Mao Z; Sheng G; Zhu Y
J Colloid Interface Sci; 2023 Jan; 629(Pt B):379-390. PubMed ID: 36162395
[TBL] [Abstract][Full Text] [Related]
6. Developing Hypoxia-Sensitive System via Designing Tumor-Targeted Fullerene-Based Photosensitizer for Multimodal Therapy of Deep Tumor.
Li L; Fu J; Ye J; Liu L; Sun Z; Wang H; Tan S; Zhen M; Wang C; Bai C
Adv Mater; 2024 Jun; 36(23):e2310875. PubMed ID: 38450765
[TBL] [Abstract][Full Text] [Related]
7. Dissolving Microneedle-Based Cascade-Activation Nanoplatform for Enhanced Photodynamic Therapy of Skin Cancer.
Ma J; Tai Z; Li Y; Li Y; Wang J; Zhou T; Shen M; Xin R; Shen C; Zhu Q; Chen Z
Int J Nanomedicine; 2024; 19():2057-2070. PubMed ID: 38482522
[TBL] [Abstract][Full Text] [Related]
8. Programmable therapeutic nanoscale covalent organic framework for photodynamic therapy and hypoxia-activated cascade chemotherapy.
He H; Du L; Xue H; Wu J; Shuai X
Acta Biomater; 2022 Sep; 149():297-306. PubMed ID: 35811069
[TBL] [Abstract][Full Text] [Related]
9. Engineering a photosensitizer nanoplatform for amplified photodynamic immunotherapy via tumor microenvironment modulation.
Zhou Y; Ren X; Hou Z; Wang N; Jiang Y; Luan Y
Nanoscale Horiz; 2021 Feb; 6(2):120-131. PubMed ID: 33206735
[TBL] [Abstract][Full Text] [Related]
10. A prodrug hydrogel with tumor microenvironment and near-infrared light dual-responsive action for synergistic cancer immunotherapy.
Ding M; Fan Y; Lv Y; Liu J; Yu N; Kong D; Sun H; Li J
Acta Biomater; 2022 Sep; 149():334-346. PubMed ID: 35779775
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia and Singlet Oxygen Dual-Responsive Micelles for Photodynamic and Chemotherapy Therapy Featured with Enhanced Cellular Uptake and Triggered Cargo Delivery.
Guo X; Han L; Chen W; He H; Zhang W; Huang C; Wang X
Int J Nanomedicine; 2024; 19():247-261. PubMed ID: 38229704
[TBL] [Abstract][Full Text] [Related]
12. Engineered biomimetic nanoreactor for synergistic photodynamic-chemotherapy against hypoxic tumor.
Guo H; Wang L; Wu W; Guo M; Yang L; Zhang Z; Cao L; Pu F; Huang X; Shao Z
J Control Release; 2022 Nov; 351():151-163. PubMed ID: 36122895
[TBL] [Abstract][Full Text] [Related]
13. 2D Copper(II) Metalated Metal-Organic Framework Nanocomplexes for Dual-enhanced Photodynamic Therapy and Amplified Antitumor Immunity.
Chen Z; Wu Y; Yao Z; Su J; Wang Z; Xia H; Liu S
ACS Appl Mater Interfaces; 2022 Oct; 14(39):44199-44210. PubMed ID: 36165392
[TBL] [Abstract][Full Text] [Related]
14. Supramolecular micelles as multifunctional theranostic agents for synergistic photodynamic therapy and hypoxia-activated chemotherapy.
Huang X; Chen T; Mu N; Lam HW; Sun C; Yue L; Cheng Q; Gao C; Yuan Z; Wang R
Acta Biomater; 2021 Sep; 131():483-492. PubMed ID: 34265471
[TBL] [Abstract][Full Text] [Related]
15. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.
Wang Y; Xie Y; Li J; Peng ZH; Sheinin Y; Zhou J; Oupický D
ACS Nano; 2017 Feb; 11(2):2227-2238. PubMed ID: 28165223
[TBL] [Abstract][Full Text] [Related]
16. Stepwise-activatable hypoxia triggered nanocarrier-based photodynamic therapy for effective synergistic bioreductive chemotherapy.
Ihsanullah KM; Kumar BN; Zhao Y; Muhammad H; Liu Y; Wang L; Liu H; Jiang W
Biomaterials; 2020 Jul; 245():119982. PubMed ID: 32224374
[TBL] [Abstract][Full Text] [Related]
17. Silk fibroin-capped metal-organic framework for tumor-specific redox dyshomeostasis treatment synergized by deoxygenation-driven chemotherapy.
Yu H; Li Y; Zhang Z; Ren J; Zhang L; Xu Z; Kang Y; Xue P
Acta Biomater; 2022 Jan; 138():545-560. PubMed ID: 34775125
[TBL] [Abstract][Full Text] [Related]
18. Glutathione-Responsive Polymersome with Continuous Glutathione Depletion for Enhanced Photodynamic Therapy and Hypoxia-Activated Chemotherapy.
Cheng G; Tao S; Liu S; Wang P; Zhang C; Liu J; Hao C; Wang S; Guo D; Xu B
ACS Macro Lett; 2024 May; 13(5):599-606. PubMed ID: 38683197
[TBL] [Abstract][Full Text] [Related]
19. Iodinated cyanine dye-based nanosystem for synergistic phototherapy and hypoxia-activated bioreductive therapy.
Dong Y; Zhou L; Shen Z; Ma Q; Zhao Y; Sun Y; Cao J
Drug Deliv; 2022 Dec; 29(1):238-253. PubMed ID: 35001784
[TBL] [Abstract][Full Text] [Related]
20. An albumin-binding dimeric prodrug nanoparticle with long blood circulation and light-triggered drug release for chemo-photodynamic combination therapy against hypoxia-induced metastasis of lung cancer.
Luo R; Zhang Z; Han L; Xue Z; Zhang K; Liu F; Feng F; Xue J; Liu W; Qu W
Biomater Sci; 2021 May; 9(10):3718-3736. PubMed ID: 34008617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
